Nervous System News and Research RSS Feed - Nervous System News and Research

The nervous system is an organ system containing a network of specialized cells called neurons that coordinate the actions of an animal and transmit signals between different parts of its body. In most animals the nervous system consists of two parts, central and peripheral. The central nervous system contains the brain and spinal cord.
Scientists create new eye technology for detecting Alzheimer's before onset of symptoms

Scientists create new eye technology for detecting Alzheimer's before onset of symptoms

Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe - in the back of the eye - progression of the disease before the onset of symptoms. [More]
Scientists succeed in restoring multiple key aspects of vision in mice

Scientists succeed in restoring multiple key aspects of vision in mice

Experiments conducted under the leadership of a Stanford University School of Medicine investigator have succeeded, for the first time, in restoring multiple key aspects of vision in mammals. [More]
Scientists discover network of flows that distribute messenger substances in the brain

Scientists discover network of flows that distribute messenger substances in the brain

We have all bumped our heads at some point, and such incidents are usually harmless. This is thanks to fluid-filled chambers in our brain that offset minor knocks and jolts and provide padding for sensitive components of our nervous system. [More]
Deadly bacteria can travel to the brain and spinal cord in 24 hours, new study finds

Deadly bacteria can travel to the brain and spinal cord in 24 hours, new study finds

A deadly bacteria that can be picked up by a simple sniff can travel to the brain and spinal cord in just 24 hours, a new Griffith University and Bond University study has found. [More]
AAN, ABF and MDA offer new two-year clinical training fellowship in muscular dystrophy

AAN, ABF and MDA offer new two-year clinical training fellowship in muscular dystrophy

The American Academy of Neurology, the American Brain Foundation and the Muscular Dystrophy Association have announced a new Clinical Research Training Fellowship in muscular dystrophy for 2017. [More]
AAN announces winners of 2016 Neuro Film Festival

AAN announces winners of 2016 Neuro Film Festival

The American Academy of Neurology is pleased to announce the winning entries to the 2016 Neuro Film Festival. [More]
Transplant drug rapamycin may reduce nerve damage, neuropathic pain after spinal cord injury

Transplant drug rapamycin may reduce nerve damage, neuropathic pain after spinal cord injury

New research in mice indicates that a drug commonly used to suppress the immune system in recipients of organ transplants may also reduce tissue damage and neuropathic pain after spinal cord injury. The findings are published in the Journal of Orthopaedic Research. [More]
Athletes may experience long-term brain changes after sports-related concussion

Athletes may experience long-term brain changes after sports-related concussion

New research finds white matter changes in the brains of athletes six months after a concussion. The study will be presented at the Sports Concussion Conference in Chicago, July 8-10, hosted by the American Academy of Neurology, the world's leading authority on the diagnosis and management of sports-related concussion. [More]
Study proves cells can send ephrins and Ephs out to transmit signals

Study proves cells can send ephrins and Ephs out to transmit signals

Eph receptors and their partner proteins, the ephrins, are vital for intercellular communication. [More]
New research shows how cholesterol medicine has beneficial effect on immune defence system

New research shows how cholesterol medicine has beneficial effect on immune defence system

The cholesterol medicine simvastatin, which is one of the most commonly used pharmaceuticals in the world, also has a beneficial effect on the immune defence system with regard to diseases such as type 1 diabetes, multiple sclerosis and rheumatoid arthritis. [More]
Sub-sensory vibratory noise leads to greater postural control, improved mobility in older adults

Sub-sensory vibratory noise leads to greater postural control, improved mobility in older adults

Researchers from the Harvard affiliated Hebrew SeniorLife Institute for Aging Research, have published a recent article in the Journal of NeuroEngineering and Rehabilitation which gives evidence that sub-sensory vibrations delivered to the foot sole of older adults significantly augmented the physiologic complexity of postural control and led to improvement in a given mobility assessment. [More]
Daclizumab drug offers new treatment option for people living with relapsing forms of MS in the UK

Daclizumab drug offers new treatment option for people living with relapsing forms of MS in the UK

A new, first-in-class treatment which is believed to use a double-action approach to fight MS by rebalancing the immune system, has today been authorised in the UK for people living with relapsing forms (the most common type) of the disease. [More]
Genetic risk score may help detect Alzheimer's disease risk in healthy young adults

Genetic risk score may help detect Alzheimer's disease risk in healthy young adults

New research shows that a genetic risk score may detect those at higher risk for Alzheimer's disease long before symptoms appear—even possibly in healthy young adults, according to a study published in the July 6, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Minoryx Therapeutics initiates phase 1 clinical trial of MIN-102

Minoryx Therapeutics initiates phase 1 clinical trial of MIN-102

Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan diseases, today announces the initiation of its first-in-man Phase 1 clinical trial for its lead compound MIN-102. [More]
RedHill Biopharma and IntelGenx announce definitive agreement for commercialization of RIZAPORT™ for migraines with Grupo JUSTE in Spain and additional potential territories

RedHill Biopharma and IntelGenx announce definitive agreement for commercialization of RIZAPORT™ for migraines with Grupo JUSTE in Spain and additional potential territories

RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases and cancer, together with IntelGenx Corp., a Canadian drug delivery company focused on oral drug delivery, today announced the signing of an exclusive license agreement with Grupo JUSTE S.A.Q.F (“Grupo JUSTE”), for the commercialization of RIZAPORT™ in Spain, and a right of first refusal for additional territories. RIZAPORT™ is a proprietary oral thin film formulation of rizatriptan for the treatment of acute migraines. [More]
Conceptual model highlights transmission of chronic pain risk from parent to children

Conceptual model highlights transmission of chronic pain risk from parent to children

Can an increased risk of chronic pain be transmitted from parents to children? Several factors may contribute, including genetics, effects on early development, social learning, and more according to a report in the journal PAIN, the official publication of the International Association for the Study of Pain. [More]
Study finds no substantial link between gadolinium exposure and parkinsonism

Study finds no substantial link between gadolinium exposure and parkinsonism

In a study appearing in the July 5 issue of JAMA, Blayne Welk, M.D., M.Sc., of Western University, London, Canada, and colleagues conducted a study to assess the association between gadolinium exposure and parkinsonism, a degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination. [More]
Researchers identify astroglia-mediated mechanism for causing FXS symptoms in mice

Researchers identify astroglia-mediated mechanism for causing FXS symptoms in mice

A study published today in the Journal of Neuroscience led by Yongjie Yang of Tufts University School of Medicine identifies an astroglial trigger mechanism as contributing to symptoms of fragile X syndrome in mice. [More]
Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses. [More]
Study shows how pasta consumption is linked to reduced likelihood of general, abdominal obesity

Study shows how pasta consumption is linked to reduced likelihood of general, abdominal obesity

In recent years pasta gained a bad reputation: it will fatten you. This led lots of people to limit its consumption, often as part of some aggressive "do it yourself" diets. Now a study conducted by the Department of Epidemiology, I.R.C.C.S. Neuromed in Pozzilli, Italy, does justice to this fundamental element of the Mediterranean diet, showing how pasta consumption is actually associated with a reduced likelihood of both general and abdominal obesity. [More]
Advertisement
Advertisement